Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Antibiotic Treatment for Appendicitis Does Not Obviate Surgery

By HospiMedica International staff writers
Posted on 07 Dec 2021
A new study suggests that although antibiotic therapy can prevent or delay an appendectomy, 50% of patients will eventually require surgery.

Researchers at the University of Washington (UW; Seattle, USA), Beth Israel Deaconess Medical Center (Boston, MA, USA), and other institutions conducted a study involving 1,552 patients with appendicitis at (414 of them with an appendicolith) who were randomized to receive antibiotics (776; 47% of whom were not hospitalized for the index treatment) or undergo appendectomy (776; 96% of whom underwent a laparoscopic procedure). More...
The primary outcome was 30-day health status.

The results showed that although 20% of patients still needed an appendectomy within 30 days of beginning a 10-day antibiotic regimen, the percentage of patients in the antibiotics group who later underwent appendectomy was 40% after one year, 46% after two years, and was higher in patients with an appendicolith. The risks tended to plateau after two years, but the number of patients who were studied for that long was smaller. The study was published on October 25, 2021, in The New England Journal of Medicine.

“For the treatment of appendicitis, antibiotics were non-inferior to appendectomy, on the basis of results of a standard health-status measure,” concluded lead author David Flum, MD, of the UW School of Medicine, and colleagues. “In the antibiotics group, nearly three in ten participants had undergone appendectomy by 90 days. Participants with an appendicolith were at a higher risk for appendectomy and for complications than those without an appendicolith.”

An appendicolith is a calcified deposit of fecal matter within the appendix. They are present in a large number of children with acute appendicitis, and may be an incidental finding on an abdominal radiograph or CT. The presence of an appendicolith is an independent prognostic risk factor for treatment failure in non-operative treatment of uncomplicated acute appendicitis, and it has also been shown to be associated with appendiceal perforation.

Related Links:
University of Washington
Beth Israel Deaconess Medical Center



Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.